정형외과용 바이오소재 시장 규모, 점유율, 동향 분석 보고서 : 재료별, 용도별, 지역별, 부문별 예측(2024-2030년)

Orthopedic Biomaterials Market Growth & Trends:

The global orthopedic biomaterials market size is expected to reach USD 35.90 billion by 2030, growing at a CAGR of 7.5% from 2024 to 2030, according to a new study by Grand View Research, Inc. Several key factors, including the increasing prevalence of orthopedic conditions and advancements in biomaterial technology, drive the market. Due to an aging population and active lifestyles, the rising incidence of musculoskeletal disorders, such as osteoarthritis and fractures, is significantly boosting the demand for orthopedic biomaterials. Moreover, technological innovations, such as the development of advanced composites and smart biomaterials, enhance the performance and integration of these materials in orthopedic implants and prosthetics, thereby expanding their application and effectiveness.

The increasing prevalence of musculoskeletal disorders and chronic skeletal conditions is fueling the market growth.According to the 2023 HSE Report, approximately 473,000 workers in Great Britain experienced work-related musculoskeletal disorders (MSDs), resulting in the loss of around 6.6 million working days. These disorders accounted for 27% of all work-related ill health cases. The growing focus on minimally invasive surgical techniques also contributes to market growth. Orthopedic biomaterials that support less invasive procedures, such as bioresorbable materials and improved implant coatings, are gaining traction due to their potential to reduce recovery times and complications. The increased investment in research and development, rising healthcare expenditures, and awareness about advanced orthopedic solutions further propels the market, making it a dynamic and rapidly evolving sector.

The rising prevalence of trauma cases is also driving the demand for orthopedic biomaterials. According to an article published by WHO in June 2022, road accidents kill approximately 1.3 million people worldwide, and approximately 20 to 50 million people suffer from non-fatal injuries. These injuries often require orthopedic surgery, leading to an increased demand for orthopedic biomaterials.

Orthopedic Biomaterials Market Report Highlights:

• By material, ceramics & bioactive glass segment accounted for the highest revenue share in 2023. The growth is attributed to the increased adoption of ceramics in the repair of hard tissues in various procedures
• By application, orthopedic implants segment accounted for the largest market share in 2023. The growth is owed to the rising incidences of disc degenerative conditions and bone fractures coupled with increasing trauma case
• In 2023, North America dominated the overall market with a revenue share of 36.2% due to the rising adoption of advanced products for bone void filling and implant load-bearing purposes

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Material
  • 1.2.2. Application
  • 1.2.3. Regional Scope
  • 1.2.4. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Material outlook
  • 2.2.2. Application outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Orthopedic Biomaterials Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. Orthopedic Biomaterials Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Orthopedic Biomaterials Market: Material Estimates & Trend Analysis

• 4.1. Material Segment Dashboard
• 4.2. Orthopedic Biomaterials Market: Material Movement Analysis
• 4.3. Orthopedic Biomaterials Market by Material Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Ceramics & Bioactive Glass Biomaterials
  • 4.5.1. Ceramics & Bioactive Glass Biomaterials Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Polymers Biomaterials
  • 4.6.1. Polymers Biomaterials Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Calcium Phosphate Cements
  • 4.7.1. Calcium Phosphate Cements Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.8. Metal Biomaterials
  • 4.8.1. Metal Biomaterials Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.9. Composites
  • 4.9.1. Composites Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Orthopedic Biomaterials Market: Application Estimates & Trend Analysis

• 5.1. Application Segment Dashboard
• 5.2. Orthopedic Biomaterials Market: Application Movement Analysis
• 5.3. Orthopedic Biomaterials Market by Application Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Orthopedic Implants
  • 5.5.1. Orthopedic Implants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Joint Replacement/reconstruction
  • 5.6.1. Joint Replacement/Reconstruction Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Orthobiologics
  • 5.7.1. Orthobiologics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. Visco Supplementation
  • 5.8.1. Visco Supplementation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.9. Bio-resorbable Tissue Fixation
  • 5.9.1. Bio-resorbable Tissue Fixation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million

Chapter 6. Orthopedic Biomaterials Market: Regional Estimates & Trend Analysis

• 6.1. Regional Dashboard
• 6.2. Regional Orthopedic Biomaterials Market Movement Analysis
• 6.3. Orthopedic Biomaterials Market: Regional Estimates & Trend Analysis by Material and Applications
• 6.4. North America
  • 6.4.1. North America Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.2. U.S.
    • 6.4.2.1. Key Country Dynamics
    • 6.4.2.2. Competitive Scenario
    • 6.4.2.3. Regulatory Framework
    • 6.4.2.4. U.S. Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.3. Canada
    • 6.4.3.1. Key Country Dynamics
    • 6.4.3.2. Competitive Scenario
    • 6.4.3.3. Regulatory Framework
    • 6.4.3.4. Canada Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4.4. Mexico
    • 6.4.4.1. Key Country Dynamics
    • 6.4.4.2. Competitive Scenario
    • 6.4.4.3. Regulatory Framework
    • 6.4.4.4. Mexico Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Europe
  • 6.5.1. Europe Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.2. UK
    • 6.5.2.1. Key Country Dynamics
    • 6.5.2.2. Competitive Scenario
    • 6.5.2.3. Regulatory Framework
    • 6.5.2.4. UK Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.3. Germany
    • 6.5.3.1. Key Country Dynamics
    • 6.5.3.2. Competitive Scenario
    • 6.5.3.3. Regulatory Framework
    • 6.5.3.4. Germany Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.4. France
    • 6.5.4.1. Key Country Dynamics
    • 6.5.4.2. Competitive Scenario
    • 6.5.4.3. Regulatory Framework
    • 6.5.4.4. France Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.5. Italy
    • 6.5.5.1. Key Country Dynamics
    • 6.5.5.2. Competitive Scenario
    • 6.5.5.3. Regulatory Framework
    • 6.5.5.4. Italy Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.6. Spain
    • 6.5.6.1. Key Country Dynamics
    • 6.5.6.2. Competitive Scenario
    • 6.5.6.3. Regulatory Framework
    • 6.5.6.4. Spain Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.7. Norway
    • 6.5.7.1. Key Country Dynamics
    • 6.5.7.2. Competitive Scenario
    • 6.5.7.3. Regulatory Framework
    • 6.5.7.4. Norway Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.8. Sweden
    • 6.5.8.1. Key Country Dynamics
    • 6.5.8.2. Competitive Scenario
    • 6.5.8.3. Regulatory Framework
    • 6.5.8.4. Sweden Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5.9. Denmark
    • 6.5.9.1. Key Country Dynamics
    • 6.5.9.2. Competitive Scenario
    • 6.5.9.3. Regulatory Framework
    • 6.5.9.4. Denmark Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Asia Pacific
  • 6.6.1. Asia Pacific Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.2. Japan
    • 6.6.2.1. Key Country Dynamics
    • 6.6.2.2. Competitive Scenario
    • 6.6.2.3. Regulatory Framework
    • 6.6.2.4. Japan Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.3. China
    • 6.6.3.1. Key Country Dynamics
    • 6.6.3.2. Competitive Scenario
    • 6.6.3.3. Regulatory Framework
    • 6.6.3.4. China Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.4. India
    • 6.6.4.1. Key Country Dynamics
    • 6.6.4.2. Competitive Scenario
    • 6.6.4.3. Regulatory Framework
    • 6.6.4.4. India Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.5. South Korea
    • 6.6.5.1. Key Country Dynamics
    • 6.6.5.2. Competitive Scenario
    • 6.6.5.3. Regulatory Framework
    • 6.6.5.4. South Korea Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.6. Australia
    • 6.6.6.1. Key Country Dynamics
    • 6.6.6.2. Competitive Scenario
    • 6.6.6.3. Regulatory Framework
    • 6.6.6.4. Australia Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6.7. Thailand
    • 6.6.7.1. Key Country Dynamics
    • 6.6.7.2. Competitive Scenario
    • 6.6.7.3. Regulatory Framework
    • 6.6.7.4. Thailand Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Latin America
  • 6.7.1. Latin America Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.2. Brazil
    • 6.7.2.1. Key Country Dynamics
    • 6.7.2.2. Competitive Scenario
    • 6.7.2.3. Regulatory Framework
    • 6.7.2.4. Brazil Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7.3. Argentina
    • 6.7.3.1. Key Country Dynamics
    • 6.7.3.2. Competitive Scenario
    • 6.7.3.3. Regulatory Framework
    • 6.7.3.4. Argentina Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. Middle East & Africa
  • 6.8.1. Middle East & Africa Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.2. South Africa
    • 6.8.2.1. Key Country Dynamics
    • 6.8.2.2. Competitive Scenario
    • 6.8.2.3. Regulatory Framework
    • 6.8.2.4. South Africa Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.3. Saudi Arabia
    • 6.8.3.1. Key Country Dynamics
    • 6.8.3.2. Competitive Scenario
    • 6.8.3.3. Regulatory Framework
    • 6.8.3.4. Saudi Arabia Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.4. UAE
    • 6.8.4.1. Key Country Dynamics
    • 6.8.4.2. Competitive Scenario
    • 6.8.4.3. Regulatory Framework
    • 6.8.4.4. UAE Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8.5. Kuwait
    • 6.8.5.1. Key Country Dynamics
    • 6.8.5.2. Competitive Scenario
    • 6.8.5.3. Regulatory Framework
    • 6.8.5.4. Kuwait Orthopedic Biomaterials Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

• 7.1. Market Participant Categorization
• 7.2. Key Company Profiles
  • 7.2.1. DSM Biomedical
    • 7.2.1.1. Company overview
    • 7.2.1.2. Financial performance
    • 7.2.1.3. Product benchmarking
    • 7.2.1.4. Strategic initiatives
  • 7.2.2. Evonik industries AG
    • 7.2.2.1. Company overview
    • 7.2.2.2. Financial performance
    • 7.2.2.3. Product benchmarking
    • 7.2.2.4. Strategic initiatives
  • 7.2.3. Stryker Corp
    • 7.2.3.1. Company overview
    • 7.2.3.2. Financial performance
    • 7.2.3.3. Product benchmarking
    • 7.2.3.4. Strategic initiatives
  • 7.2.4. Depuy Synthes Inc
    • 7.2.4.1. Company overview
    • 7.2.4.2. Financial performance
    • 7.2.4.3. Product benchmarking
    • 7.2.4.4. Strategic initiatives
  • 7.2.5. Zimmer Biomet
    • 7.2.5.1. Company overview
    • 7.2.5.2. Financial performance
    • 7.2.5.3. Product benchmarking
    • 7.2.5.4. Strategic initiatives
  • 7.2.6. Invibo Ltd.
    • 7.2.6.1. Company overview
    • 7.2.6.2. Financial performance
    • 7.2.6.3. Product benchmarking
    • 7.2.6.4. Strategic initiatives
  • 7.2.7. Globus Medical
    • 7.2.7.1. Company overview
    • 7.2.7.2. Financial performance
    • 7.2.7.3. Product benchmarking
    • 7.2.7.4. Strategic initiatives
  • 7.2.8. . Exactech, Inc.
    • 7.2.8.1. Company overview
    • 7.2.8.2. Financial performance
    • 7.2.8.3. Product benchmarking
    • 7.2.8.4. Strategic initiatives
  • 7.2.9. Matexcel
    • 7.2.9.1. Company overview
    • 7.2.9.2. Financial performance
    • 7.2.9.3. Product benchmarking
    • 7.2.9.4. Strategic initiatives
  • 7.2.10. AdvanSource
    • 7.2.10.1. Company overview
    • 7.2.10.2. Financial performance
    • 7.2.10.3. Product benchmarking
    • 7.2.10.4. Strategic initiatives
  • 7.2.11. Biomaterials Corp
    • 7.2.11.1. Company overview
    • 7.2.11.2. Financial performance
    • 7.2.11.3. Product benchmarking
    • 7.2.11.4. Strategic initiatives
  • 7.2.12. CAM Bioceramics B.V.
    • 7.2.12.1. Company overview
    • 7.2.12.2. Financial performance
    • 7.2.12.3. Product benchmarking
    • 7.2.12.4. Strategic initiatives
  • 7.2.13. Heraeus Holding
    • 7.2.13.1. Company overview
    • 7.2.13.2. Financial performance
    • 7.2.13.3. Product benchmarking
    • 7.2.13.4. Strategic initiatives